Minimizing the Risks of Anticoagulants and Platelet Inhibitors

Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry

(2009) Eric M. Crespo et al.   AMERICAN HEART JOURNAL

Predictors of Early Discontinuation of Evidence-Based Medicine After Acute Coronary Syndrome

(2009) Chiara Melloni et al.   AMERICAN JOURNAL OF CARDIOLOGY

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

(2009) D. N. Juurlink et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction

(2009) Susan Cheng et al.   CIRCULATION

Clopidogrel and the Concept of High-Risk Pharmacokinetics

(2009) Dan M. Roden et al.   CIRCULATION

Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice

(2009) Tracy Y. Wang et al.   CIRCULATION

Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel

(2009) Jessica L. Mega et al.   CIRCULATION

Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction

(2009) Sumeet Subherwal et al.   CIRCULATION

Medication Adherence

(2009) P. Michael Ho et al.   CIRCULATION

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

(2009) C. Varenhorst et al.   EUROPEAN HEART JOURNAL

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

(2009) R. Mehran et al.   EUROPEAN HEART JOURNAL

Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome

(2009) P. Michael Ho   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention

(2009) Brendan J. Doyle et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Combining Antiplatelet and Anticoagulant Therapies

(2009) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pharmacogenetics in Cardiovascular Antithrombotic Therapy

(2009) Francisco Marín et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Advanced Age, Antithrombotic Strategy, and Bleeding in Non–ST-Segment Elevation Acute Coronary Syndromes

(2009) Renato D. Lopes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Interaction Between Cigarette Smoking and Clinical Benefit of Clopidogrel

(2009) Nihar R. Desai et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hemostasis and thrombosis in older adults

(2009) S. Michael Gharacholou et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

(2009) Richard C Becker et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

(2009) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight-Based Dosing of Enoxaparin in Obese Patients with Non–ST-Segment Elevation Acute Coronary Syndromes: Results from the CRUSADE Initiative

(2009) Sarah A Spinler et al.   PHARMACOTHERAPY

Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy

(2008) Shamir R. Mehta et al.   AMERICAN HEART JOURNAL

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

(2008) Herbert D. Aronow et al.   AMERICAN HEART JOURNAL

Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])

(2008) Joel M. Gore et al.   AMERICAN JOURNAL OF CARDIOLOGY

G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy

(2008) Susan S. Smyth et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Parenteral Anticoagulants

(2008) Jack Hirsh et al.   CHEST

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

(2008) Stephen D. Wiviott et al.   CIRCULATION

Antiplatelet Therapy Use After Discharge Among Acute Myocardial Infarction Patients With In-Hospital Bleeding

(2008) Tracy Y. Wang et al.   CIRCULATION

Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention

(2008) D. Sibbing et al.   EUROPEAN HEART JOURNAL

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

(2008) A. Budaj et al.   EUROPEAN HEART JOURNAL

Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)

(2008) A J Chase et al.   HEART

Major Femoral Bleeding Complications After Percutaneous Coronary Intervention

(2008) Brendan J. Doyle et al.   JACC-Cardiovascular Interventions

Fluoroscopy-Guided Femoral Artery Puncture Reduces the Risk of PCI-Related Vascular Complications

(2008) James Fitts et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy

(2008) Harvey D. White et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

(2008) Martine Gilard et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents

(2008) Dietmar Trenk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

(2008) Harlan M. Krumholz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genetic Determinants of Response to Warfarin during Initial Anticoagulation

(2008) Ute I. Schwarz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

(2008) Tabassome Simon et al.   NEW ENGLAND JOURNAL OF MEDICINE